Nu-Med Plus (NUMD) Selling, General & Administrative (2012 - 2026)
Powered by 
Analysis
Nu-Med Plus (NUMD) Selling, General & Administrative (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 4.03 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 617.90 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 3.20 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 2.23 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 1.80 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 561.20 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -964.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 358.70 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 369.70 Mn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | 8,073.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8,073.00 |
| Dec 31, 2025 | 6,069.00 |
| Sep 30, 2025 | 5,872.00 |
| Jun 30, 2025 | 5,469.00 |
| Mar 31, 2025 | 5,705.00 |
| Dec 31, 2024 | 6,037.00 |
| Sep 30, 2024 | 9,467.00 |
| Jun 30, 2024 | 12,835.00 |
| Mar 31, 2024 | 5,984.00 |
| Dec 31, 2023 | 5,722.00 |
| Sep 30, 2023 | 8,846.00 |
| Jun 30, 2023 | 6,573.00 |
| Mar 31, 2023 | 6,416.00 |
| Dec 31, 2022 | 6,669.00 |
| Sep 30, 2022 | 5,702.00 |
| Jun 30, 2022 | 11,238.00 |
| Mar 31, 2022 | 2,961.00 |
| Dec 31, 2021 | 11,566.00 |
| Sep 30, 2021 | 6,947.00 |
| Jun 30, 2021 | 5,936.00 |